C

Medexus Pharmaceuticals Inc. MEDXF

OTC PK
Recommendation
Dividend Power Score
Day's Range
$3.80$3.88
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 17.62% 16.13% -0.41% -15.56% -5.94%
Total Other Revenue -- -- -- -- --
Total Revenue 17.62% 16.13% -0.41% -15.56% -5.94%
Cost of Revenue 21.90% 21.86% -9.68% -28.33% -19.32%
Gross Profit 15.34% 13.11% 5.83% -5.66% 3.18%
SG&A Expenses 11.63% 6.77% -13.02% 2.23% 23.00%
Depreciation & Amortization -0.49% -0.54% 0.82% 38.04% 54.06%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 15.47% 11.39% -8.18% -9.77% 3.99%
Operating Income 47.61% 148.71% 671.38% -55.70% -59.68%
Income Before Tax 474.01% -18.54% -296.31% -49.32% 43.72%
Income Tax Expenses 3,516.67% -143.43% -61.65% 148.98% 98.26%
Earnings from Continuing Operations 358.10% 5.43% -383.73% -89.09% -386.36%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 358.10% 5.43% -383.73% -89.09% -386.36%
EBIT 47.61% 148.71% 671.38% -55.70% -59.68%
EBITDA 18.99% 38.19% 98.24% -25.97% -28.10%
EPS Basic 364.29% 6.88% -342.78% -91.58% -317.78%
Normalized Basic EPS 2,530.00% 1,860.00% 94.98% -61.43% -102.09%
EPS Diluted 359.00% 6.88% -342.78% -91.58% -332.56%
Normalized Diluted EPS 2,530.00% 1,860.00% 94.98% -61.43% -102.16%
Average Basic Shares Outstanding -2.65% -1.33% 9.08% 31.42% 31.53%
Average Diluted Shares Outstanding -2.65% -1.33% 9.08% 31.42% 27.12%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --